These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11922881)

  • 1. Monoamine depletion in unmedicated depressed subjects.
    Berman RM; Sanacora G; Anand A; Roach LM; Fasula MK; Finkelstein CO; Wachen RM; Oren DA; Heninger GR; Charney DS
    Biol Psychiatry; 2002 Mar; 51(6):469-73. PubMed ID: 11922881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy.
    Neumeister A; Turner EH; Matthews JR; Postolache TT; Barnett RL; Rauh M; Vetticad RG; Kasper S; Rosenthal NE
    Arch Gen Psychiatry; 1998 Jun; 55(6):524-30. PubMed ID: 9633671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?
    Berman RM; Narasimhan M; Miller HL; Anand A; Cappiello A; Oren DA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1999 May; 56(5):395-403. PubMed ID: 10232292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients.
    Miller HL; Delgado PL; Salomon RM; Heninger GR; Charney DS
    Neuropsychopharmacology; 1996 Mar; 14(3):151-7. PubMed ID: 8866698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in depressive response during monoamine depletions in remitted depressive subjects.
    Moreno FA; McGahuey CA; Freeman MP; Delgado PL
    J Clin Psychiatry; 2006 Oct; 67(10):1618-23. PubMed ID: 17107256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.
    Hasler G; Fromm S; Carlson PJ; Luckenbaugh DA; Waldeck T; Geraci M; Roiser JP; Neumeister A; Meyers N; Charney DS; Drevets WC
    Arch Gen Psychiatry; 2008 May; 65(5):521-31. PubMed ID: 18458204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls.
    Homan P; Drevets WC; Hasler G
    Psychopharmacology (Berl); 2014 Jan; 231(2):409-17. PubMed ID: 23954912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to catecholamine depletion in unmedicated, remitted subjects with major depressive disorder and healthy controls.
    Homan P; Drevets WC; Hasler G
    J Clin Psychopharmacol; 2013 Oct; 33(5):621-6. PubMed ID: 23963054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy.
    Stastny J; Konstantinidis A; Schwarz MJ; Rosenthal NE; Vitouch O; Kasper S; Neumeister A
    Biol Psychiatry; 2003 Feb; 53(4):332-7. PubMed ID: 12586452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals.
    Haynes PL; McQuaid JR; Kelsoe J; Rapaport M; Gillin JC
    J Affect Disord; 2004 Dec; 83(2-3):253-62. PubMed ID: 15555723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of behavioral effects of monoamine depletion in healthy subjects.
    Salomon RM; Miller HL; Krystal JH; Heninger GR; Charney DS
    Biol Psychiatry; 1997 Jan; 41(1):58-64. PubMed ID: 8988796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression.
    Czermak C; Hauger R; Drevets WC; Luckenbaugh DA; Geraci M; Charney DS; Neumeister A
    J Affect Disord; 2008 Oct; 110(3):277-81. PubMed ID: 18281099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Heninger GR; Gelenberg AJ; Charney DS
    Psychopharmacol Bull; 1993; 29(3):389-96. PubMed ID: 8121966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
    Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.
    Delgado PL; Price LH; Miller HL; Salomon RM; Aghajanian GK; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):865-74. PubMed ID: 7944875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms.
    Homan P; Grob S; Milos G; Schnyder U; Hasler G
    Psychoneuroendocrinology; 2013 Sep; 38(9):1545-52. PubMed ID: 23333252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral responses to catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa and healthy subjects.
    Grob S; Stern J; Gamper L; Moergeli H; Milos G; Schnyder U; Hasler G
    Biol Psychiatry; 2015 Apr; 77(7):661-7. PubMed ID: 24209774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects.
    Neumeister A; Yuan P; Young TA; Bonne O; Luckenbaugh DA; Charney DS; Manji H
    Am J Psychiatry; 2005 Apr; 162(4):805-7. PubMed ID: 15800160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion.
    O'Reardon JP; Cristancho P; Pilania P; Bapatla KB; Chuai S; Peshek AD
    Depress Anxiety; 2007; 24(8):537-44. PubMed ID: 17131353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined catecholamine and indoleamine depletion following response to ECT.
    Cassidy F; Weiner RD; Cooper TB; Carroll BJ
    Br J Psychiatry; 2010 Jun; 196(6):493-4. PubMed ID: 20513863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.